DELVINO, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 3.891
NA - Nord America 2.433
EU - Europa 1.832
SA - Sud America 727
Continente sconosciuto - Info sul continente non disponibili 258
AF - Africa 94
OC - Oceania 19
Totale 9.254
Nazione #
US - Stati Uniti d'America 2.283
SG - Singapore 1.026
IT - Italia 842
CN - Cina 738
VN - Vietnam 702
BR - Brasile 542
HK - Hong Kong 504
RU - Federazione Russa 349
JP - Giappone 186
BD - Bangladesh 181
FR - Francia 129
KR - Corea 119
IN - India 104
GB - Regno Unito 84
DE - Germania 81
AR - Argentina 74
CA - Canada 73
TR - Turchia 66
ES - Italia 61
SE - Svezia 61
ID - Indonesia 51
IQ - Iraq 44
MX - Messico 41
NL - Olanda 33
CO - Colombia 30
PK - Pakistan 27
FI - Finlandia 25
VE - Venezuela 25
ZA - Sudafrica 25
SA - Arabia Saudita 24
UA - Ucraina 24
CH - Svizzera 23
EC - Ecuador 22
IE - Irlanda 20
PL - Polonia 19
UZ - Uzbekistan 18
AU - Australia 16
AT - Austria 14
KE - Kenya 13
MA - Marocco 13
CL - Cile 12
PH - Filippine 12
TW - Taiwan 12
BE - Belgio 11
EG - Egitto 10
TH - Thailandia 10
CR - Costa Rica 9
LB - Libano 9
AL - Albania 8
AZ - Azerbaigian 8
JM - Giamaica 7
PE - Perù 7
TN - Tunisia 7
UY - Uruguay 7
ET - Etiopia 6
GR - Grecia 6
HR - Croazia 6
IL - Israele 6
MY - Malesia 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
NP - Nepal 5
PA - Panama 5
PY - Paraguay 5
SY - Repubblica araba siriana 5
BY - Bielorussia 4
HN - Honduras 4
JO - Giordania 4
LT - Lituania 4
LV - Lettonia 4
NI - Nicaragua 4
PT - Portogallo 4
QA - Qatar 4
AO - Angola 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
SN - Senegal 3
CI - Costa d'Avorio 2
GE - Georgia 2
NO - Norvegia 2
OM - Oman 2
RE - Reunion 2
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
DM - Dominica 1
GH - Ghana 1
IM - Isola di Man 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 8.984
Città #
Singapore 563
Hong Kong 494
San Jose 348
Ashburn 324
Milan 254
Hefei 243
Ho Chi Minh City 216
Hanoi 202
Seoul 114
Los Angeles 96
Beijing 90
Rome 88
The Dalles 83
Dallas 78
Chicago 71
Santa Clara 61
Ann Arbor 60
New York 60
Tokyo 59
Lauterbourg 51
Turin 46
Moscow 45
São Paulo 44
Buffalo 41
Shanghai 36
Toronto 34
Jakarta 32
Council Bluffs 30
Da Nang 25
Paris 24
Frankfurt am Main 22
Madrid 22
Rio de Janeiro 21
Dublin 20
Biên Hòa 19
Boardman 19
Haiphong 18
Osaka 18
Columbus 17
Florence 17
Quận Bình Thạnh 17
Tashkent 17
Ankara 16
Baghdad 16
Orem 16
Guangzhou 15
Atlanta 14
Belo Horizonte 14
Bogotá 14
London 14
Chennai 13
Hải Dương 13
Istanbul 13
Mexico City 13
Montreal 13
Riyadh 13
Stockholm 13
Amsterdam 12
Buenos Aires 12
Denver 12
Houston 12
Princeton 12
Seattle 12
Caracas 11
Charlotte 11
Johannesburg 11
Kent 11
Lappeenranta 11
Mumbai 11
Nuremberg 11
Quito 11
Ryōke 11
Washington 11
Brooklyn 10
Carate Brianza 10
Fairfield 10
Figino 10
Nairobi 10
Salt Lake City 10
Salvador 10
Wilmington 10
Bologna 9
Boston 9
Dhaka 9
Munich 9
San José 9
Vienna 9
Warsaw 9
Brasília 8
Brescia 8
Brussels 8
Chandler 8
Ha Long 8
Helsinki 8
Manaus 8
Manchester 8
Recife 8
Ribeirão Preto 8
San Francisco 8
Vũng Tàu 8
Totale 4.770
Nome #
Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group 593
Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control study 410
Systemic vasculitis: one year in review 2024 308
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 302
Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles 256
Approccio innovativo agli unmet needs nella gestione a lungo termine dei pazienti affetti da vasculite ANCA-associata 239
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study 229
Novel insights into the management of rheumatoid arthritis: one year in review 2024 216
Systemic vasculitis: one year in review 2022 207
Humoral and T-cell immune response following three doses of SARS-CoV-2 mRNA vaccine in giant cell arteritis: analysis of a prospective cohort 203
Systemic vasculitis: one year in review 2025 194
Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis 189
Factors influencing patient-reported outcomes in ANCA-associated vasculitis: correlates of the Patient Global Assessment 173
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study 172
Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual 170
Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: A prospective analysis 164
Clinical picture, outcomes and predictors of relapse in eosinophilia-associated coronary vasospasm: data from a European multicentric study 162
Clinical outcomes of subglottic stenosis in granulomatosis with polyangiitis: results of an international multicentre observational study 155
Nivolumab and ipilimumab-induced eosinophilic granulomatosis with polangiitis in a patient treated with dupilumab 152
A 28-Year-Old Man with Stridor and Dyspnea 151
One year in review 2020: vasculitis 150
Massive abdominal haemorrhage due to sequential omental vasculitis and ruptured aneurysms in a patient with granulomatosis with polyangiitis 145
Clinical Image: Extensive subcutaneous calcinosis cutis with fistulization in refractory dermatomyositis 144
Azathioprine vs methotrexate in eosinophilic granulomatosis with polyangiitis: a monocentric retrospective study 144
Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target 143
Asma, EGPA, HES: elementi di diagnostica differenziale 142
Impact of mepolizumab on patient-reported outcomes in eosinophilic granulomatosis with polyangiitis by using the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire 136
The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis: report of two cases and review of the literature 133
Safety of BNT162b2 mRNA COVID-19 vaccine in a cohort of elderly, immunocompromised patients with systemic vasculitis 130
Novel Therapies for ANCA-associated Vasculitis 129
Set the scene: Key points dell’Inquadramento e diagnosi differenziale dell’EGPA 129
Fast-Track Ultrasound Clinic for the Diagnosis of Giant Cell Arteritis Changes the Prognosis of the Disease but Not the Risk of Future Relapse 127
Quale approccio diagnostico al paziente con iper-eosinofilia? 127
Asma ed ipereosinofilia 121
The role of trimethoprim/sulfametoxazole in reducing relapses and risk of infections in ANCA-associated vasculitis: a meta-analysis 118
Severe immunoglobulin A vasculitis with refractory gastrointestinal involvement in an adult patient successfully treated with plasma exchange 117
A New Era for the Early and Non‐Invasive Diagnosis of Giant Cell Arteritis: The Use of Fast‐Track Ultrasound in Clinical Practice 115
Systemic vasculitis: one year in review 2023 115
Long-term maintenance of remission with spacing of rituximab infusions based on the individualised patient risk profile in ANCA-associated vasculitis: a pilot study 115
Update on Treatment of Antisynthetase Syndrome: A Brief Review 115
Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis 111
Cytomegalovirus colitis unmasking human immunodeficiency virus infection as a cause of IgA vasculitis 110
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies 104
Prevalence of Whipple's disease in north-western Italy 103
ANCA-Associated Vasculitides and Polyarteritis Nodosa - EULAR on-line course on Rheumatic Diseases 101
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 101
Impact of immunosuppressive treatment on the immunogenicity of mRNA COVID-19 vaccine in vulnerable patients with giant cell arteritis 96
Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs' 94
Impact of delayed diagnoses at the time of COVID-19: Increased rate of preventable bilateral blindness in giant cell arteritis 94
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 93
Lumbar spondylolisthesis associated with systemic sclerosis-related spinal calcinosis: an unusual clinical case 92
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 91
One year in review 2021: Systemic vasculitis 89
Is it really infective endocarditis? Distinguishing systemic vasculitis from its mimics 88
An unusual reno-pulmonary complication in the course of systemic sclerosis 84
Striking abdominal aortic stenosis revealing Takayasu's arteritis 82
Early detection and risk stratification in autoimmune-related interstitial lung disease: a state-of-the-art review 82
Overlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter study 82
Erratum: Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis (Rheumatology (2020) 59 (e125-e127) DOI: 10.1093/rheumatology/keaa184) 79
Asma e poliposi nasale: quando preoccuparsi? 78
Beyond Oral Anticoagulants Two case reports of Biopsy-Proven Heparin-Induced Anticoagulant-Related Nephropathy 69
Systemic vasculitis: one year in review 2026 51
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study 20
Current management of eosinophilic granulomatosis with polyangiitis across Europe: insights from a multinational expert survey 17
Addressing unmet needs in uncontrolled asthma through a specialized severe asthma center 3
Totale 9.254
Categoria #
all - tutte 29.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.470


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202287 0 15 7 11 14 8 10 1 3 4 4 10
2022/202372 8 18 6 2 3 12 8 5 7 0 3 0
2023/2024355 0 1 5 5 8 12 12 1 133 11 50 117
2024/20252.863 155 274 68 113 170 99 197 85 224 340 302 836
2025/20265.299 623 482 440 565 352 240 671 280 424 466 277 479
2026/2027534 352 182 0 0 0 0 0 0 0 0 0 0
Totale 9.254